REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Novaya Apteka OOO (Zarechnyi) (Новая Аптека ООО (Заречный)) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Novaya Apteka OOO Profile Updated: October 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Novaya Apteka OOO (Zarechnyi) (Новая Аптека ООО (Заречный)) is an enterprise in Russia, with the main office in Zarechnyi. It operates in the Pharmacies and Drug Stores sector. The company was established on August 09, 2013. There was a net sales revenue increase of 15.41% reported in Novaya Apteka OOO (Zarechnyi) (Новая Аптека ООО (Заречный))’s latest financial highlights for 2024. Its total assets decreased by 36.63% over the same period. The enterprise’s net profit margin increased by 3.36% in 2024.

Headquarters
Lenina, 25, 3
Zarechnyi; Sverdlovsk Oblast; Postal Code: 624250

Contact Details: Purchase the Novaya Apteka OOO (Zarechnyi) (Новая Аптека ООО (Заречный)) report to view the information.

Basic Information
Registered Capital:
Purchase the Novaya Apteka OOO (Zarechnyi) (Новая Аптека ООО (Заречный)) report to view the information.
Financial Auditors:
Purchase the Novaya Apteka OOO (Zarechnyi) (Новая Аптека ООО (Заречный)) report to view the information.
Incorporation Date:
August 09, 2013
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novaya Apteka OOO (Zarechnyi) (Новая Аптека ООО (Заречный)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
15.41%▲
Total operating revenue
15.41%▲
Operating profit (EBIT)
92.73%▲
Net Profit (Loss) for the Period
113.57%▲
Total Assets
-36.63%▼
Total Equity
-48.88%▼
Operating Profit Margin (ROS)
3.33%▲
Net Profit Margin
3.36%▲
Return on Equity (ROE)
96.85%▲
Quick Ratio
-1.07%▼
Cash Ratio
-0.19%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo